IRIS
BRAVACCINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 277
NA - Nord America 148
AS - Asia 139
OC - Oceania 2
Totale 566
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 158
US - Stati Uniti d'America 148
SG - Singapore 134
DE - Germania 40
IT - Italia 20
NL - Olanda 20
FI - Finlandia 19
CZ - Repubblica Ceca 6
FR - Francia 6
CN - Cina 5
AT - Austria 4
RU - Federazione Russa 3
AU - Australia 2
GB - Regno Unito 1
Totale 566
Salva come PNG Salva come JPEG
Città #
Dublin 158
Boardman 129
Singapore 88
Munich 24
Amsterdam 19
Helsinki 19
Ashburn 11
Milan 7
Brno 6
Lugo 5
Chicago 4
Vienna 4
Paris 3
Nuremberg 2
Crescentino 1
Frankfurt am Main 1
Fuzhou 1
Gatchina 1
Purmerend 1
Rimini 1
Shanghai 1
St Petersburg 1
Stockton-on-Tees 1
Villa Cortese 1
Totale 489
Salva come PNG Salva come JPEG
Nome #
Urinary Biomarkers in Tumors: An Overview 13
The use of platelets as a clinical tool in oncology: opportunities and challenges 12
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance 12
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 10
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 10
Biomarkers: which ones do we really need today? 10
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer 10
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) 10
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 10
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? 10
Androgen receptor in breast cancer: The "5W" questions 10
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 9
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 9
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer 9
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa 9
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? 9
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer 9
Molecular characterization of cytotoxic and drug resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines 9
Androgen receptor signaling pathways as a target for breast cancer treatment 9
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 9
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study 9
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 9
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 8
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa 8
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 8
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 8
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 8
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 8
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis 8
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 8
International consensus on severe lung cancer-the first edition 8
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 8
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 8
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer 8
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer 8
Sorafenib for the treatment of breast cancer 8
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer 8
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit) 8
TMB in NSCLC: A Broken Dream? 7
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells 7
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) 7
Urine telomerase: An important marker in the diagnosis of bladder cancer 7
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 7
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study 7
Expanding Roles of De Novo Lipogenesis in Breast Cancer 7
Combined analysis of miR-200 family and its significance for breast cancer 7
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 7
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 7
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 7
Usefulness of immunological detection of the human telomerase reverse transcriptase 7
What to look for in cell-free DNA from breast cancer patients 7
Are we ready to use TMB in breast cancer clinical practice? 7
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 6
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report 6
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report 6
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization 6
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 6
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country 6
CAR T cells targeting options in the fight against multiple myeloma 6
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. 6
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy 6
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer 6
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 6
Benefit from anthracyclines in relation to biological profiles in early breast cancer 6
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology 5
Biofunctional characteristics of in situ and invasive breast carcinoma 5
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance 5
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients 5
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 5
Relevance of urine telomerase in the diagnosis of bladder cancer 5
Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania 5
Why the complications of COVID-19 patients differ in elderly and young cancer patients 5
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer 5
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold 5
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer 5
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression 5
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer" 5
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma 5
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 5
The current role of telomerase in the diagnosis of bladder cancer 4
Primary epithelioid angiosarcoma of the thyroid: A case report 4
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 4
What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors? 4
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations 4
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling 4
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue 4
High consistency between characteristics of primary intraductal breast cancer and subtype of subsequent ipsilateral invasive cancer 4
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 4
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy 4
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China 4
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study 4
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer 4
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence 4
Explaining the aggressiveness of breast cancer in sub-Saharan African patients 4
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 4
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 3
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis 3
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 3
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 3
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 3
Totale 668
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024187 0 0 0 0 0 0 0 0 0 0 0 187
2024/2025568 264 71 193 40 0 0 0 0 0 0 0 0
Totale 755